{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T14:10:25Z","timestamp":1795183825918,"version":"4.10.3"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Use of interferon-gamma releasing assays (IGRAs) in children &lt;2 years old may derive many of the same advantages, which have led to preference over tuberculin skin test (TST) in older children, but data are limited. Since 2011, we have tested children &lt;2 years old with Quantiferon-TB Gold\/Gold Plus (QFT)) in select clinical scenarios at Denver Health, a health system encompassing a TB clinic, refugee and immigrant screening and primary care.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We identified patients &lt;2 years old tested with QFT between February, 2011 and August, 2019. The primary outcome measure was incident cases of TB among tested patients. Test results and in vitro characteristics were analyzed, as were demographic, epidemiologic and clinical outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>We analyzed 116 QFTs ordered in children age 7\u201323 months. Two were positive, 3 indeterminate, 3 failed\/refused phlebotomy and the remainder (93%) were negative. Mitogen tube results were robust. Thirteen patients were TST-positive: 11 were QFT-negative, 1 QFT-positive and 1 failed phlebotomy. Eight patients received some form of TB medication, including 4 QFT-negative patients who were treated for active TB or latent TB infection based on positive TST or clinical findings. Among QFT-negative patients, including 6 TST-positive, not treated for active TB or latent TB infection, no TB disease has been identified over a median follow-up time of 2.96 years.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>IGRA use was not limited by barriers of phlebotomy, indeterminate result or gamma-interferon production. The risk of missing an infected but IGRA-negative patient can be reduced by treatment of select patients at higher risk. Current recommendations against IGRA use in children &lt;2 years old could be amended to allow careful introduction, particularly among well-appearing BCG-vaccinated patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000002711","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T07:42:21Z","timestamp":1587627741000},"page":"803-807","source":"Crossref","is-referenced-by-count":14,"title":["Interferon-Gamma Release Assay Testing in Children Younger Than 2 Years in a US-Based Health System"],"prefix":"10.1097","volume":"39","author":[{"given":"James","family":"Gaensbauer","sequence":"first","affiliation":[{"name":"Denver Metro Tuberculosis Clinic, Denver Public Health, Denver, CO"},{"name":"Department of Pediatrics, Denver Health Medical Center, Denver, CO"},{"name":"Department of Pediatrics, University of Colorado School of Medicine"},{"name":"Center for Global Health, Colorado School of Public Health, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Denver Health Medical Center, Denver, CO"},{"name":"Department of Pediatrics, University of Colorado School of Medicine"},{"name":"Denver Health Refugee Clinic, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Harasaki","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Denver Health Medical Center, Denver, CO"},{"name":"Department of Pediatrics, University of Colorado School of Medicine"},{"name":"Denver Health Refugee Clinic, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaylynn","family":"Aiona","sequence":"additional","affiliation":[{"name":"Denver Metro Tuberculosis Clinic, Denver Public Health, Denver, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Belknap","sequence":"additional","affiliation":[{"name":"Denver Metro Tuberculosis Clinic, Denver Public Health, Denver, CO"},{"name":"Department of Infectious Diseases, Denver Health Medical Center, Denver, CO"},{"name":"Department of Infectious Diseases, University of Colorado School of Medicine, Aurora, CO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle K.","family":"Haas","sequence":"additional","affiliation":[{"name":"Denver Metro Tuberculosis Clinic, Denver Public Health, Denver, CO"},{"name":"Department of Infectious Diseases, Denver Health Medical Center, Denver, CO"},{"name":"Department of Infectious Diseases, University of Colorado School of Medicine, Aurora, CO."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,4,21]]},"reference":[{"key":"R1-20230912","first-page":"392","article-title":"The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era.","volume":"8","author":"Marais","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1542\/peds.2011-3048","article-title":"Risk factors for in-hospital mortality among children with tuberculosis: the 25-year experience in Peru.","volume":"130","author":"Drobac","year":"2012","journal-title":"Pediatrics"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/thoraxjnl-2015-207687","article-title":"The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: evidence to be considered when screening children for tuberculosis infection.","volume":"71","author":"Seddon","year":"2016","journal-title":"Thorax"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/cid\/ciw778","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention Clinical Practice Guidelines: diagnosis of Tuberculosis in Adults and Children.","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1086\/519266","article-title":"Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis.","volume":"45","author":"Detjen","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"e20191930","DOI":"10.1542\/peds.2019-1930","article-title":"Interferon-\u03b3 release assays in children <15 years of age.","volume":"145","author":"Ahmed","year":"2020","journal-title":"Pediatrics"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/039463201202500301","article-title":"Interferon-\u03b3 release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a systematic review and meta-analysis.","volume":"25","author":"Chiappini","year":"2012","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1574-695X.2011.00838.x","article-title":"Interferon gamma release assay in diagnosis of pediatric tuberculosis: a meta-analysis.","volume":"63","author":"Sun","year":"2011","journal-title":"FEMS Immunol Med Microbiol"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.5588\/ijtld.10.0631","article-title":"Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis.","volume":"15","author":"Mandalakas","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12879-016-1461-y","article-title":"Performance of interferon-\u03b3 release assays in the diagnosis of confirmed active tuberculosis in immunocompetent children: a new systematic review and meta-analysis.","volume":"16","author":"Laurenti","year":"2016","journal-title":"BMC Infect Dis"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"e20173918","DOI":"10.1542\/peds.2017-3918","article-title":"Interferon-gamma release assay performance for tuberculosis in childhood.","volume":"141","author":"Kay","year":"2018","journal-title":"Pediatrics"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/jpids\/piu119","article-title":"Interferon-gamma release assays and pediatric public health tuberculosis screening: the San Francisco Program Experience 2005 to 2008.","volume":"5","author":"Grinsdale","year":"2016","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jpeds.2018.04.034","article-title":"Interferon-Gamma release assay-based screening for pediatric latent tuberculosis infection in an Urban Primary Care Network.","volume":"200","author":"Gaensbauer","year":"2018","journal-title":"J Pediatr"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3201\/eid2503.181596","article-title":"Window period prophylaxis for children exposed to tuberculosis, Houston, TX, USA, 2007-2017.","volume":"25","author":"Cruz","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"R20-20230912","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/INF.0b013e3181a16394","article-title":"The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status.","volume":"28","author":"Haustein","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R21-20230912","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jpeds.2012.04.007","article-title":"The effect of age on whole blood interferon-gamma release assay response among children investigated for latent tuberculosis infection.","volume":"161","author":"Critselis","year":"2012","journal-title":"J Pediatr"},{"key":"R22-20230912","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jinf.2013.06.011","article-title":"QuantiFERON to diagnose infection by Mycobacterium tuberculosis: performance in infants and older children.","volume":"67","author":"Blandini\u00e8res","year":"2013","journal-title":"J Infect"},{"key":"R23-20230912","doi-asserted-by":"crossref","first-page":"e3485","DOI":"10.1371\/journal.pone.0003485","article-title":"Natural variation in immune responses to neonatal Mycobacterium bovis Bacillus Calmette-Guerin (BCG) vaccination in a cohort of gambian infants.","volume":"3","author":"Finan","year":"2008","journal-title":"PLoS One"},{"key":"R24-20230912","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1128\/CVI.13.2.246-252.2006","article-title":"Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers.","volume":"13","author":"Van Rie","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"R25-20230912","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/597069","article-title":"Population differences in immune responses to Bacille Calmette-Gu\u00e9rin vaccination in infancy.","volume":"199","author":"Lalor","year":"2009","journal-title":"J Infect Dis"},{"key":"R26-20230912","doi-asserted-by":"crossref","first-page":"E54","DOI":"10.1542\/peds.107.4.e54","article-title":"Targeted testing of children for tuberculosis: validation of a risk assessment questionnaire.","volume":"107","author":"Froehlich","year":"2001","journal-title":"Pediatrics"},{"key":"R27-20230912","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(00)02554-X","article-title":"Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity.","volume":"356","author":"Cobelens","year":"2000","journal-title":"Lancet"},{"key":"R28-20230912","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jama.285.4.451","article-title":"Evaluation of a risk assessment questionnaire used to target tuberculin skin testing in children.","volume":"285","author":"Ozuah","year":"2001","journal-title":"JAMA"},{"key":"R29-20230912","doi-asserted-by":"crossref","first-page":"e0213304","DOI":"10.1371\/journal.pone.0213304","article-title":"Sensitivity and characteristics associated with positive QuantiFERON-TB Gold-Plus assay in children with confirmed tuberculosis.","volume":"14","author":"Nguyen","year":"2019","journal-title":"PLoS One"},{"key":"R30-20230912","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.diagmicrobio.2012.11.023","article-title":"Antigen-specific CD4- and CD8-positive signatures in different phases of Mycobacterium tuberculosis infection.","volume":"75","author":"Nikolova","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R31-20230912","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1183\/13993003.00510-2016","article-title":"First evaluation of QuantiFERON-TB Gold Plus performance in contact screening.","volume":"48","author":"Barcellini","year":"2016","journal-title":"Eur Respir J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002711","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T23:04:21Z","timestamp":1694559861000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,21]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002711","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,21]]}}}